473 related articles for article (PubMed ID: 15956162)
1. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.
Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM
Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162
[TBL] [Abstract][Full Text] [Related]
2. A case of frontotemporal dementia and parkinsonism of early onset with progressive supranuclear palsy-like features.
Miyamoto K; Ikemoto A; Akiguchi I; Kohno R; Imura T; Fujita Y
Clin Neuropathol; 2001; 20(1):8-12. PubMed ID: 11220696
[TBL] [Abstract][Full Text] [Related]
3. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
[TBL] [Abstract][Full Text] [Related]
4. Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra.
Noureddine MA; Li YJ; van der Walt JM; Walters R; Jewett RM; Xu H; Wang T; Walter JW; Scott BL; Hulette C; Schmechel D; Stenger JE; Dietrich F; Vance JM; Hauser MA
Mov Disord; 2005 Oct; 20(10):1299-309. PubMed ID: 15966006
[TBL] [Abstract][Full Text] [Related]
5. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Bukhatwa S; Zeng BY; Rose S; Jenner P
Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
[TBL] [Abstract][Full Text] [Related]
6. Calbindin-D28k in the basal ganglia of patients with parkinsonism.
Ito H; Goto S; Sakamoto S; Hirano A
Ann Neurol; 1992 Oct; 32(4):543-50. PubMed ID: 1456738
[TBL] [Abstract][Full Text] [Related]
7. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Jellinger KA
Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
[TBL] [Abstract][Full Text] [Related]
8. [A 65-year-old man with Parkinsonism, gaze palsy, and dementia].
Mizuno Y; Yokochi F; Ohta S; Mori H; Takubo H
No To Shinkei; 1996 Apr; 48(4):381-93. PubMed ID: 8679336
[TBL] [Abstract][Full Text] [Related]
9. A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene.
Soliveri P; Rossi G; Monza D; Tagliavini F; Piacentini S; Albanese A; Bugiani O; Girotti F
Arch Neurol; 2003 Oct; 60(10):1454-6. PubMed ID: 14568818
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.
Hirano S; Shinotoh H; Shimada H; Aotsuka A; Tanaka N; Ota T; Sato K; Ito H; Kuwabara S; Fukushi K; Irie T; Suhara T
Brain; 2010 Jul; 133(Pt 7):2058-68. PubMed ID: 20558417
[TBL] [Abstract][Full Text] [Related]
11. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
[TBL] [Abstract][Full Text] [Related]
12. Excessive dopamine neuron loss in progressive supranuclear palsy.
Murphy KE; Karaconji T; Hardman CD; Halliday GM
Mov Disord; 2008 Mar; 23(4):607-10. PubMed ID: 18163454
[TBL] [Abstract][Full Text] [Related]
13. Familial progressive supranuclear palsy.
Gazeley S; Maguire JA
Clin Neuropathol; 1996; 15(4):215-20. PubMed ID: 8836606
[TBL] [Abstract][Full Text] [Related]
14. Altered gene expression profiles reveal similarities and differences between Parkinson disease and model systems.
Miller RM; Federoff HJ
Neuroscientist; 2005 Dec; 11(6):539-49. PubMed ID: 16282595
[TBL] [Abstract][Full Text] [Related]
15. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra.
Rinne JO; Rummukainen J; Paljärvi L; Rinne UK
Ann Neurol; 1989 Jul; 26(1):47-50. PubMed ID: 2549846
[TBL] [Abstract][Full Text] [Related]
16. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
17. Subcortical neurofibrillary tangles and argyrophilic grains in a case of familial frontotemporal dementia with parkinsonism.
Kobayashi K; Sudo S; Matsubara R; Nakano H; Koshino Y
Parkinsonism Relat Disord; 2008 Aug; 14(6):513-6. PubMed ID: 18346925
[TBL] [Abstract][Full Text] [Related]
18. Topographic investigation of brain atrophy in parkinsonism-dementia complex of Guam: a comparison with Alzheimer's disease and progressive supranuclear palsy.
Oyanagi K; Makifuchi T; Ohtoh T; Ikuta F; Chen KM; Chase TN; Gajdusek DC
Neurodegeneration; 1994 Dec; 3(4):301-4. PubMed ID: 7842300
[TBL] [Abstract][Full Text] [Related]
19. Parkinsonism and extraocular motor abnormalities with unusual neuropathological findings.
Calabrese VP; Hadfield MG
Mov Disord; 1991; 6(3):257-60. PubMed ID: 1922131
[TBL] [Abstract][Full Text] [Related]
20. Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease.
Miller RM; Kiser GL; Kaysser-Kranich TM; Lockner RJ; Palaniappan C; Federoff HJ
Neurobiol Dis; 2006 Feb; 21(2):305-13. PubMed ID: 16143538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
